title: Improvement of quality of life in patients with chronic inflammatory demyelinating polyneuropathy shifting from 16 to 20% subcutaneous immunoglobulins.
authors.affiliation: Neurologia IV, Department of Neurosciences, University of Turin, Via Cherasco 15, 10126, Turin, Italy, dariococito@yahoo.it.
authors.forename: Dario
authors.initials: D
authors.lastname: Cocito
authors.forename: Ilaria
authors.initials: I
authors.lastname: Paolasso
authors.forename: Erdita
authors.initials: E
authors.lastname: Peci
authors.forename: Emanuela
authors.initials: E
authors.lastname: Spagone
authors.forename: Leonardo
authors.initials: L
authors.lastname: Lopiano
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage* / Q000627:therapeutic use; D007155:Immunologic Factors / Q000008:administration & dosage* / Q000627:therapeutic use; D055104:Infusions, Subcutaneous; D008297:Male; D008875:Middle Aged; D020277:Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Q000188:drug therapy*; D011788:Quality of Life; D055815:Young Adult
chemical_list: D007136:Immunoglobulins; D007155:Immunologic Factors